For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
First steps: What’s the dope on patient safety and medical marijuana prescribing?
+Print Archive
Etcetera
First steps: What’s the dope on patient safety and medical marijuana prescribing?
Wednesday 11 September 2019, 03:00 AM

First steps:
This month, our registrar panel was asked about navigating currently ambiguous medical marijuana prescribing rules
I have discovered it’s unclear whether the medical marijuana regulations under development will require cannabis medicines to have Medsafe approval – , STEPHANIE TAYLOR, Stephenie Taylor
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.